Ethical Considerations in Pharmaceutical Marketing and Commercialization: Navigating Persuasion, Disclosure, And Regulatory Accountability
DOI:
https://doi.org/10.65150/EP-jmrr/V2E9/2026-01Keywords:
pharmaceutical marketing ethics, direct-to-consumer advertising, commercialization, conflicts of interest, algorithmic targeting, drug pricing, health equity, regulatory governance.Abstract
Pharmaceutical marketing occupies a contested position between two legitimate but frequently opposing aims: the commercial imperative to generate return on investment in drug development, and the ethical obligation to protect patients whose therapeutic decisions carry consequences no ordinary consumer purchase carries. This paper examines how that tension has been reshaped during 2025 and 2026 by four simultaneous developments: an abrupt reversal in United States enforcement of direct-to-consumer (DTC) advertising rules, the migration of promotion into algorithmic and creator-driven digital channels, the emergence of manufacturer-owned direct-to-patient distribution that collapses the boundary between marketing and dispensing, and the introduction of most-favored-nation (MFN) pricing frameworks that recast commercialization strategy as an instrument of foreign and industrial policy. Drawing on regulatory documents, enforcement records, and peer-reviewed literature published between January 2025 and August 2026, the analysis identifies six cross-cutting ethical problems: the manipulation gap between persuasion and the exploitation of cognitive vulnerability, the disclosure paradox in which transparency substitutes for genuine understanding, the erosion of the learned intermediary as a functional safeguard, the misalignment of transparency instruments with the conduct they were designed to reveal, the global externalities of nationally framed pricing reforms, and the capability gap between stated ethical commitment and the organizational capacity to execute it. The paper argues that compliance-based ethics has become structurally inadequate, and proposes an accountability framework organized around channel-neutral duties, algorithmic auditability, verified clinical intermediation, and disclosure of the terms under which access is granted.
References
1) Abah, M. A., Okwah, M. N., Oladosu, M. A., Yohanna, N. R., & Blessing, C. T. (2025a). Advances in the management of hypertension: A review of current guidelines, pharmacological therapies, and lifestyle interventions. Drug and Pharmaceutical Science Archives, 5(4), 35-41. https://doi.org/10.47587/DAP.2025.5401
2) Abah, M. A., Okwah, M. N., Oladosu, M. A., Yohanna, N. R., Blessing, C. T., & Vanessa, O. I. (2025b). The impact of lifestyle modifications on cardiovascular health: A review of diet, exercise, and stress reduction intervention. Drug and Pharmaceutical Science Archives, 5(3), 26-34. https://doi.org/10.47587/DAP.2025.5301
3) Abdulhadi, B. M., & Hamdan, A. M. (2026a). Carbon-driven decision gates: Integrating embodied carbon accounting into construction project lifecycle governance. Research Journal of Pure Science and Technology, 9(5), 48-82.
https://doi.org/10.56201/rjpst.vol.9.no5.2026.pg48.82 [Conceptual framework paper.]
4) Abdulhadi, B. M., & Hamdan, A. M. (2026b). Net-zero project delivery: A maturity model for carbon management capability in construction organizations. International Journal of Engineering and Modern Technology, 12(6), 199-233.
https://doi.org/10.56201/ijemt.vol.12.no6.2026.pg199.233 [Conceptual maturity model paper.]
5) Abetoh, N. F., & Atakpa, M. I. (2024). Audit analytics in healthcare financial oversight: Leveraging data science to strengthen accountability in multilateral grant ecosystems. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 10(6), 2710-2747. https://doi.org/10.32628/CSEIT2410791
6) Abioye, R. F., Okojie, J. S., Filani, O. M., Ike, P. N., Idu, J. O. O., Nnabueze, S. B., Okojokwu-Idu, J. O., & Ihwughwavwe, S. I. (2023). Automated ESG reporting in energy projects using blockchain-driven smart compliance management systems. International Journal of Multidisciplinary Evolutionary Research, 4(2), 120-129. https://doi.org/10.54660/IJMER.2023.4.2.120-129
7) Abramova, R., Filatova, M., Sazonava, M., & Serikova, K. (2026). Ethical and practical aspects of AI implementation in the pharmaceutical industry. International Journal of Pharmaceutical and Healthcare Marketing, 20(1), 238–268.https://doi.org/10.1108/IJPHM-10-2024-0103
8) Adebayo, A., Adepoju, P. A., & Ozowara, D. E. (2023). Conceptual model for cyber risk pricing and insurance structuring in health technology platforms. Gyanshauryam, International Scientific Refereed Research Journal, 6(6).
9) Adebayo, A., Anunagba, C. O., & Ozowara, D. E. (2025). A review of zero trust security models and cost effectiveness in healthcare infrastructure. International Journal of Advanced Multidisciplinary Research and Studies, 5(6), 2269-2283.
https://doi.org/10.62225/2583049X.2025.5.6.6051
10) Adelanwa, A., Basnet, A., & Anene, U. N. (2023a). Data driven digital transformation models for lifecycle performance management in infrastructure delivery. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2646-2662.
https://doi.org/10.62225/2583049X.2023.3.6.5968
11) Adelanwa, A., Basnet, A., & Anene, U. N. (2023b). Predictive analytics models for financial risk detection and fraud prevention in public systems. International Journal of Advanced Multidisciplinary Research and Studies, 3(6).https://doi.org/10.62225/2583049X.2023.3.6.5969
12) Adelanwa, A., Basnet, A., & Anene, U. N. (2024). Performance intelligence models for optimization and outcome measurement in large scale public services. Shodhshauryam, International Scientific Refereed Research Journal, 6(1).
13) Adelanwa, A., Basnet, A., & Anene, U. N. (n.d.). Advanced AI-based decision support systems for healthcare operations and resource planning. Gyanshauryam, International Scientific Refereed Research Journal, 7(1).
14) Afrihyia, E., Akinse, S. G., & Ojukwu, P. U. (2023). Development and implementation of an AI-driven early detection system for non-communicable diseases. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2680-2691.
15) Afrihyia, E., Akinse, S. G., & Ojukwu, P. U. (2024a). Comparative governance of AI-driven healthcare management: Executive oversight, regulatory structures, and accountability in the United States and developing countries. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 3087-3102. https://doi.org/10.62225/2583049X.2024.4.6.5920
16) Afrihyia, E., Akinse, S. G., & Ojukwu, P. U. (2025). Organizational readiness for generative AI integration in healthcare operations: Comparative management capabilities between the U.S. and low- and middle-income countries. Iconic Research and Engineering Journals, 8(10), 1673-1697. https://doi.org/10.64388/IREV8I10-1714670
17) Afrihyia, E., Ojukwu, P. U., & Akinse, S. G. (2024b). Privacy-preserving health data governance models: A comparative review of blockchain and cryptographic strategies in U.S. and developing healthcare systems. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 3071-3086. https://doi.org/10.62225/2583049X.2024.4.6.5919
18) Agu, M. U., Akomolafe, O., & Bello, A. (2023a). A comparative review of SOX compliance frameworks in cross-border financial auditing. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2297-2306.
https://doi.org/10.62225/2583049X.2023.3.6.5362
19) Agu, M. U., Akomolafe, O., & Bello, A. (2023b). A review of integrated data management systems for enhancing financial forecasting accuracy. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2335-2344.
20) Agu, M. U., Akomolafe, O., & Bello, A. (2025). Advances in predictive financial risk assessment using Python-based forecasting systems. International Journal of Computer Science and Mathematical Theory, 11(11), 131-148.
https://doi.org/10.56201/ijcsmt.vol.11.no11.2025.pg131.148
21) Aifuwa, S. E., Oshoba, T. O., Ogbuefi, E., Ike, P. N., Nnabueze, S. B., & Olatunde-Thorpe, J. (2020). Predictive analytics models enhancing supply chain demand forecasting accuracy and reducing inventory management inefficiencies. International Journal of Multidisciplinary Research and Growth Evaluation, 1(3), 171-181. https://doi.org/10.54660/.IJMRGE.2020.1.3.171-181
22) Akin-Oluyomi, O. T., Atima, M. E., & Akinleye, O. K. (2023a). Green procurement strategies for balancing cost efficiency with long-term environmental responsibility. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2183-2193.
23) Akin-Oluyomi, O. T., Atima, M. E., & Akinleye, O. K. (2023b). Regulatory compliance and supplier risk assessment frameworks in international pharmaceutical procurement. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2194-2204.
24) Akin-Oluyomi, O. T., Atima, M. E., & Akinleye, O. K. (2024). Cross-border supplier relationship management frameworks for pharmaceutical and global construction sectors. International Journal of Multidisciplinary Research and Growth Evaluation, 5(6), 1709-1718.
25) Akin-Oluyomi, O. T., Atima, M. E., Akinleye, O. K., & Akokodaripon, D. A. (2020). Using Tableau and Excel for comprehensive profitability analysis in retail procurement operations. International Journal of Multidisciplinary Research and Growth Evaluation, 1(5), 385-393.
26) Akin-Oluyomi, O. T., Atima, M. E., Akinleye, O. K., & Okoruwa, P. O. (2023c). Predictive analytics approaches for improving demand forecasting accuracy in e-commerce procurement systems. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2173-2182.
27) Akin-Oluyomi, O. T., Okoruwa, P. O., Babatope, O. M., & Akokodaripon, D. A. (2023d). Evaluating supplier sustainability metrics through data-driven procurement and supply chain frameworks. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2213-2223.
28) Akinse, S. G., Ekechi, N. V., & Ohanebo, C. G. (2023a). Integrative maternal health model: Addressing socioeconomic inequities in rural populations. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2832-2838.
29) Akinse, S. G., Ohanebo, C. G., & Ekechi, N. V. (2023b). A trauma-informed educational framework for adolescents in underserved communities. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 9(10), 434-443. https://doi.org/10.32628/CSEIT2361073
30) Akintola, A. S., Fawehinmi, Y. O., Aiyenitaju, O., Chinemerem, B., & Emmanuella, O. (2025). Digital transformation in telehealth: A systematic review of user trust, privacy, and regulatory governance in AI-powered remote monitoring systems. Journal of Scientific Research and Reports, 31(11), 163-182. https://doi.org/10.9734/jsrr/2025/v31i113658
31) Akomolafe, O., & Agu, M. U. (2018). A conceptual model for enhancing internal audit quality through technology-enabled risk assessment frameworks. Iconic Research and Engineering Journals, 1(9), 458-475.
32) Akomolafe, O., & Agu, M. U. (2019a). A conceptual framework for developing risk-based internal control models in the insurance and banking sectors. Iconic Research and Engineering Journals, 2(8), 335-354.
33) Akomolafe, O., & Agu, M. U. (2019b). A review of data-driven risk evaluation models for emerging market financial institutions. Iconic Research and Engineering Journals, 3(6), 433-448.
34) Aliliele, C., Mbonu, I. S., & Iwuanyanwu, U. (2023a). A conceptual framework for continuous cloud misconfiguration monitoring and enterprise risk mitigation strategies. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 9(10), 373-394. https://doi.org/10.32628/CSEIT2361071
35) Aliliele, C., Mbonu, I. S., & Iwuanyanwu, U. (2023b). A review of API governance and risk prioritization frameworks in modern financial institutions. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 9(10), 395-433. https://doi.org/10.32628/CSEIT2361072
36) Aliliele, C., Mbonu, I. S., & Iwuanyanwu, U. (2023c). Advances in predictive analytics models for student retention and institutional risk management systems. International Journal of Advanced Multidisciplinary Research and Studies, 3(6), 2692-2711.
https://doi.org/10.62225/2583049X.2023.3.6.5990
37) Aliliele, C., Mbonu, I. S., & Iwuanyanwu, U. (2024a). A conceptual framework for enterprise data sensitivity classification and regulatory traceability mechanisms. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 3103-3124.
https://doi.org/10.62225/2583049X.2024.4.6.5991
38) Aliliele, C., Mbonu, I. S., & Iwuanyanwu, U. (2024b). Advances in HIPAA compliant data architecture and secure analytics frameworks for community healthcare organizations. Shodhshauryam, International Scientific Refereed Research Journal, 7(2), 277-324.
https://doi.org/10.32628/SHISRRJ2472163
39) Aliliele, C., Mbonu, I. S., Uzoka, E., & Iwuanyanwu, U. (2025a). A review of AI assisted continuous auditing systems in technology risk and cybersecurity oversight. Gyanshauryam, International Scientific Refereed Research Journal, 8(4), 210-250.
https://doi.org/10.32628/GISRRJ258369
40) Aliliele, C., Mbonu, I. S., Uzoka, E., & Iwuanyanwu, U. (2025b). Advances in data lakehouse governance architectures for enterprise data loss prevention and compliance assurance. Shodhshauryam, International Scientific Refereed Research Journal, 8(4), 171-213.
https://doi.org/10.32628/SHISRRJ258474
41) Amadi, C. E., Akanbi, P. O., Okwah, M. N., Mbakwem, A. C., & Ajuluchukwu, J. N. (2026a). Triglyceride-glucose index and reduced kidney function in hypertensive Nigerian adults: Independent association within the cardio-renal continuum. BMC Cardiovascular Disorders. Advance online publication. https://doi.org/10.1186/s12872-026-05985-5
42) Amadi, C. E., Ale, O. K., Okorafor, U. C., Okwah, M. N., Akanbi, P. O., Mbakwem, A. C., & Ajuluchukwu, J. N. (2026b). Unmasking the contemporary burden of hypertension in Lagos, Nigeria: Insights from an opportunistic screening. BMC Public Health. Advance online publication. https://doi.org/10.1186/s12889-026-26310-x
43) Aminu-Ibrahim, A. Y., & Ogbete, J. C. (2023). Healthcare infrastructure as a public health intervention using evidence from large laboratory networks. Shodhshauryam, International Scientific Refereed Research Journal, 6(1), 256-286.
https://doi.org/10.32628/SHISRRJ23678
44) Aminu-Ibrahim, A. Y., Ogbete, J. C., & Ambali, K. B. (2018). Developing sustainable diagnostic laboratory infrastructure models for emerging and resource constrained health systems. Iconic Research and Engineering Journals, 1(8), 118-132.
https://doi.org/10.64388/IREV1I8-1713586
45) Aminu-Ibrahim, A. Y., Ogbete, J. C., & Ambali, K. B. (2019). Capital project delivery models for high risk healthcare infrastructure in developing national health systems. Iconic Research and Engineering Journals, 2(10), 626-649.
https://doi.org/10.64388/IREV2I10-1713588
46) Aminu-Ibrahim, A. Y., Ogbete, J. C., & Ambali, K. B. (2020). Infrastructure driven expansion of diagnostic access across underserved and rural healthcare regions. International Journal of Multidisciplinary Research and Growth Evaluation, 1(5), 691-706.
https://doi.org/10.54660/IJMRGE.2020.1.5.691-706
47) Aminu-Ibrahim, A. Y., Ogbete, J. C., & Ambali, K. B. (2024). Governance and accountability models for public private partnerships in healthcare infrastructure development. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 2943-2960.
https://doi.org/10.62225/2583049X.2024.4.6.5699
48) Aminu-Ibrahim, A. Y., Ogbete, J. C., & Iwuanyanwu, O. C. (2025a). Cost control and financial accountability frameworks for national healthcare construction programs. International Journal of Advanced Multidisciplinary Research and Studies, 5(6), 1970-1990.
https://doi.org/10.62225/2583049X.2025.5.6.5700
49) Aminu-Ibrahim, A. Y., Ogbete, J. C., & Iwuanyanwu, O. C. (2025b). Infrastructure resilience planning for national diagnostic systems under public health stress conditions. Gyanshauryam, International Scientific Refereed Research Journal, 8(1), 340-381. https://doi.org/10.32628/GISRRJ2582311
50) Aminu-Ibrahim, A. Y., Ogbete, J. C., & Iwuanyanwu, O. C. (2025c). Sustainable healthcare infrastructure performance metrics for long-term asset management and value creation. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 11(4), 566-601. https://doi.org/10.32628/CSEIT251116277
51) Anene, U. N., & Clement, T. (2022). A resilient logistics framework for humanitarian supply chains: Integrating predictive analytics, IoT, and localized distribution to strengthen emergency response systems. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 8(5), 398-424.
52) Anene, U. N., & Clement, T. (2024). Localized supply chain solutions for sustainable community development: A strategic model for economic revitalization and regional resilience. International Journal of Scientific Research in Science and Technology, 11(5).
53) Annan, A. O. (2022). Data privacy governance models for cross-border digital platforms. International Journal of Multidisciplinary Research and Growth Evaluation, 3(6), 949-964.
54) Annan, A. O. (2023). Intellectual property ownership and authorship in AI-generated works. Gyanshauryam, International Scientific Refereed Research Journal, 6(3), 425-450.
55) Annan, A. O. (2024). Algorithmic accountability and trade secret protection in artificial intelligence. Shodhshauryam, International Scientific Refereed Research Journal, 7(5), 315-347.
56) Annan, A. O. (2025a). Automated decision-making and anti-discrimination compliance under U.S. law. International Journal of Advanced Multidisciplinary Research and Studies, 5(2), 2522-2540.
57) Annan, A. O. (2025b). Cybersecurity compliance as a source of competitive advantage in technology markets. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 11(5), 456-487.
58) Asiedu, C. S., & Asiedu, A. A. (2022). Last-mile drug distribution to underserved communities: A review of barriers and intervention models. Gyanshauryam, International Scientific Refereed Research Journal, 5(6), 439-466.
59) Asiedu, C. S., & Asiedu, A. A. (2023a). Comparative bioavailability of fresh versus dried botanical compounds: A review and cost-effectiveness modelling framework. Research Journal of Pure Science and Technology, 6(3), 226-244.
https://doi.org/10.56201/rjpst.v6.no3.2023.pg226.244
60) Asiedu, C. S., & Asiedu, A. A. (2023b). Pharmaceutical supply chain inefficiencies and medication affordability in resource-constrained health systems: A narrative review. International Journal of Health and Pharmaceutical Research, 8(4), 192-222.
https://doi.org/10.56201/ijhpr.v8.no4.2023.pg192.222
61) Asiedu, C. S., & Asiedu, A. A. (2024a). Equitable access to chronic therapies in hospital pharmacy settings: A conceptual framework for continuity of care. International Journal of Medical Evaluation and Physical Report, 8(6), 274-298.
https://doi.org/10.56201/ijmepr.v8.no6.2024.pg274.298
62) Asiedu, C. S., & Asiedu, A. A. (2024b). Reconceptualizing quality assurance in pharmaceutical manufacturing as a determinant of supply reliability. International Journal of Health and Pharmaceutical Research, 9(5), 148-173.
https://doi.org/10.56201/ijhpr.v9.no5.2024.pg148.173
63) Asiedu, C. S. (2022). Drug interaction risk in antenatal care: A conceptual framework for systematic interaction screening. Shodhshauryam, International Scientific Refereed Research Journal, 5(3), 465-484.
64) Asiedu, C. S. (2023). Diagnostic integration in infectious disease management: A review of microbiology, virology, and serology workflows. International Journal of Medical Evaluation and Physical Report, 7(4), 173-195.
https://doi.org/10.56201/ijmepr.v7.no4.2023.pg173.195
65) Asiedu, C. S. (2024). Droplet digital PCR for HIV viral reservoir quantification: A review of diagnostic accuracy and clinical utility. International Journal of Medical Evaluation and Physical Report, 8(6), 253-273. https://doi.org/10.56201/ijmepr.v8.no6.2024.pg253.273
66) Asiedu, C. S. (2025). A lean process-improvement framework for pharmaceutical inventory and distribution management. International Journal of Health and Pharmaceutical Research, 10(12), 225-252. https://doi.org/10.56201/ijhpr.vol.10.no12.2025.pg225.252
67) Asiedu, C. S. (2026). Toward a systems-level framework for healthcare access, affordability, and supply chain resilience. International Journal of Health and Pharmaceutical Research, 11(5), 128-156. https://doi.org/10.56201/ijhpr.vol.11.no5.2026.pg128.156
68) Atakpa, M. I., & Abetoh, N. F. (2022). A systematic review of machine learning advances in financial fraud detection for banking systems. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 8(2), 771-801. https://doi.org/10.32628/CSEIT23906220
69) Atakpa, M. I., & Abolaji, T. O. (2022). A privacy-preserving data architecture model for regulated industry analytics under GDPR and HIPAA compliance. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 8(3), 781-808. https://doi.org/10.32628/CSEIT22558
70) Atakpa, M. I., & Fobellah, A. N. (2023). Anomaly detection in financial time-series data: A conceptual model for healthcare and banking applications. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 9(2), 967-997. https://doi.org/10.32628/CSEIT2342441
71) Atakpa, M. I. (2021). A review of predictive analytics models for anti-money laundering detection in commercial banking systems. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 7(2), 778-804. https://doi.org/10.32628/CSEIT2064813
72) Atakpa, M. I., Abetoh, N. F., & Akeju, B. (2024a). Advances in artificial intelligence for healthcare payment fraud detection: A review of NHS applications. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 10(4), 1161-1194. https://doi.org/10.32628/CSEIT26123240
73) Atakpa, M. I., Abolaji, T. O., & Abetoh, N. F. (2024b). Statistical time-series models for long-range public health trend forecasting: A review and conceptual framework. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 10(6), 2748-2780. https://doi.org/10.32628/CSEIT2410792
74) Atakpa, M. I., Abolaji, T. O., & Akeju, B. (2023). A review of natural language processing for social media-based public health surveillance and analytics. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 9(6), 1030-1060. https://doi.org/10.32628/CSEIT23906783
75) Atima, M. E., Sanni, J. O., & Attah, A. (2022). Predictive audience segmentation models resolving targeting inefficiencies in regulated professional service enterprises. Shodhshauryam, International Scientific Refereed Research Journal, 5(1), 271-303.
https://doi.org/10.32628/SHISRRJ247134
76) Basnet, A., Oghenemaiga, E., & Anene, U. N. (2021). Audience segmentation and forecasting models for enhancing targeted digital marketing effectiveness. Shodhshauryam, International Scientific Refereed Research Journal, 4(5), 279-305.
77) Basnet, A., Oghenemaiga, E., & Anene, U. N. (2023). Real time analytics and monitoring systems for livestream media performance using Google platforms. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 10(1).
78) Basnet, A., Oghenemaiga, E., & Anene, U. N. (2024). Attribution, revenue, and yield optimization models using Google Ad Manager reporting and forecasting tools. International Journal of Advanced Multidisciplinary Research and Studies, 4(6).
https://doi.org/10.62225/2583049X.2024.4.6.5667
79) Borah, S., Aliliele, K. C., Rakshit, S., & Vajjhala, N. R. (2022). Applications of artificial intelligence in software testing. In P. K. Mallick et al. (Eds.), Cognitive informatics and soft computing (Lecture Notes in Networks and Systems, Vol. 375, pp. 727-736). Springer. https://doi.org/10.1007/978-981-16-8763-1_60
80) Chambers and Partners. (2026). Pharmaceutical advertising 2026: USA. Global Practice Guides.
https://practiceguides.chambers.com/practice-guides/pharmaceutical-advertising-2026/usa
81) Council of the European Union. (2026). Pharma package: Council and Parliament reach a deal on new rules for a fairer and more competitive EU pharmaceutical sector. https://www.consilium.europa.eu/en/policies/pharma-pack/
82) Curve Compliance. (2026). Pharma DTC advertising 2026: FTC and FDA rules that changed mid-year.
https://www.curvecompliance.com/pharma-dtc-advertising-2026-ftc-fda-rules-changed-mid-year
83) Ekechi, N. V., Anunagba, C. O., & Ozowara, D. E. (2022). Advances in financial forensics techniques for detecting cyber-enabled fraud in telemedicine services. Shodhshauryam, International Scientific Refereed Research Journal, 5(1), 428-450.
84) Ekechi, N. V., Ozowara, D. E., & Anunagba, C. O. (2026). Conceptual framework for AI governance, data privacy compliance, and financial sustainability in digital health. Computer Science and IT Research Journal, 7(4), 275-299.
85) Eze, F. I., Akinleye, O. K., & Anene, U. N. (2024a). Development of a cross-border regulatory harmonization model for African pharmaceutical markets: The ARCH-Model framework. International Journal of Health and Pharmaceutical Research, 9(5), 148-186.
https://doi.org/10.56201/ijhpr.v9.no5.2024.pg148.186
86) Eze, F. I., Akinleye, O. K., & Anene, U. N. (2024b). Development of a risk-based accelerated approval decision model balancing speed, safety, and evidence quality in pharmaceutical regulatory science. Research Journal of Pure Science and Technology, 7(6), 120-161.
https://doi.org/10.56201/rjpst.v7.no6.2024.pg120.161
87) Eze, F. I., Anene, U. N., & Akinleye, O. K. (2022a). Creation of a drug shortage early warning and regulatory response model for essential medicines in global health systems. Research Journal of Pure Science and Technology, 5(1), 57-95.
https://doi.org/10.56201/rjpst.v5.no1.2022.pg57.95
88) Eze, F. I., Anene, U. N., & Akinleye, O. K. (2022b). Design of an integrated regulatory readiness maturity model for pharmaceutical companies seeking global market entry. International Journal of Health and Pharmaceutical Research, 7(1), 77-112.
https://doi.org/10.56201/ijhpr.v7.no1.2022.pg77.112
89) Eze, F. I., Anene, U. N., & Akinleye, O. K. (2023). Pharmaceutical supply chain governance, environmental risk management, and sustainable access to essential medicines in emerging economies: The PSCG-ERM framework. International Journal of Health and Pharmaceutical Research, 8(4), 192-241. https://doi.org/10.56201/ijhpr.v8.no4.2023.pg192.241
90) Fawehinmi, Y. O., Okereke, G. M. T., Williams, P., Chijioke-Churuba, J. N., & Asare-Badu, B. (2026). AI-human collaboration in education and psychology: Personalised learning, language acquisition and student support systems. Journal of Political Science and International Relationship, 3(1), 54-64. https://doi.org/10.54536/jpsir.v3i1.6998
91) Filani, O. M., Nnabueze, S. B., Ike, P. N., & Wedraogo, L. (2022). Real-time risk assessment dashboards using machine learning in hospital supply chain management systems. International Journal of Multidisciplinary Evolutionary Research, 3(1), 65-76.
https://doi.org/10.54660/IJMER.2022.3.1.65-76
92) Foley Hoag LLP. (2026, July). FDA proposes to eliminate "adequate provision" for broadcast prescription drug advertising. https://foleyhoag.com/news-and-insights/publications/alerts-and-updates/2026/july/fda-proposes-to-eliminate-adequate-provision-for-broadcast-prescription-drug-advertising/
93) Gardner Law. (2026). FDA's anticipated proposed rulemaking for direct-to-consumer prescription drug advertising.
https://gardner.law/news/fda-proposed-rule-adequate-provision-dtc-advertising
94) Health Affairs. (2026). Most favored nation policies and value-based drug pricing: A European view. Health Affairs, 45(4), 361–364.
https://doi.org/10.1377/hlthaff.2026.00115
95) Hussain, N., & Adebayo, A. (2026). The role of artificial intelligence in strengthening modern cybersecurity systems. World Journal of Innovation and Modern Technology, 10(6), 125-181. https://doi.org/10.56201/wjimt.v10.no6.2026.pg125.181
96) Ike, P. N., Aifuwa, S. E., Nnabueze, S. B., Olatunde-Thorpe, J., Ogbuefi, E., Oshoba, T. O., & Akokodaripon, D. (2024). Quantitative risk architecture for public-private partnerships: A multi-layered model for allocating public and private risk. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 2669-2682. https://doi.org/10.62225/2583049X.2024.4.6.5021
97) Ilodigwe, L., & Adesemoye, A. C. (2019a). A critical review of health insurance financing mechanisms and provider payment reform strategies for balancing coverage expansion and financial protection in emerging markets. International Journal of Health and Pharmaceutical Research, 5(2), 31-55. https://doi.org/10.56201/ijhpr.vol.5.no2.2019.pg31.55
98) Ilodigwe, L., & Adesemoye, A. C. (2019b). From molecules to health systems: A conceptual model explaining why scientific innovation fails to improve patient outcomes without effective healthcare delivery infrastructure. International Journal of Health and Pharmaceutical Research, 5(2), 56-79. https://doi.org/10.56201/ijhpr.vol.5.no2.2019.pg56.79
99) Ilodigwe, L., & Adesemoye, A. C. (2020). Advances in pharmacy-led delivery and access models for strengthening primary healthcare systems and expanding medicine availability in emerging markets. International Journal of Health and Pharmaceutical Research, 5(3), 78-96. https://doi.org/10.56201/ijhpr.vol.5.no3.2020.pg78.96
100) Ilodigwe, L., & Adesemoye, A. C. (2021). The data backbone of health system transformation: A governance and architecture framework for interoperability, data quality, and advanced analytics at national scale. International Journal of Health and Pharmaceutical Research, 6(2), 52-76. https://doi.org/10.56201/ijhpr.vol.6.no2.2021.pg52.76
101) Ilodigwe, L., & Adesemoye, A. C. (2024a). Advances in real-world evidence, predictive analytics, and data-driven decision making for improving health system performance and patient outcomes. International Journal of Health and Pharmaceutical Research, 9(5), 174-197. https://doi.org/10.56201/ijhpr.v9.no5.2024.pg174.197
102) Ilodigwe, L., & Adesemoye, A. C. (2024b). Beyond technology: A strategic framework for building sustainable and resilient health systems through organizational strategy, operational excellence, and workforce capability. International Journal of Medical Evaluation and Physical Report, 8(6), 299-319. https://doi.org/10.56201/ijmepr.v8.no6.2024.pg299.319
103) Ilodigwe, L., & Adesemoye, A. C. (2025a). Advances, risks, and implementation challenges of artificial intelligence as a force multiplier for clinical decision making and health system efficiency. International Journal of Medical Evaluation and Physical Report, 9(7), 165-185. https://doi.org/10.56201/ijmepr.v9.no7.2025.pg165.185
104) Ilodigwe, L., & Adesemoye, A. C. (2025b). Executing healthcare transformation at scale: A strategic change model derived from large programs across payers, providers, and integrated health systems. International Journal of Health and Pharmaceutical Research, 10(12), 253-272. https://doi.org/10.56201/ijhpr.vol.10.no12.2025.pg253.272
105) Ilodigwe, L., & Adesemoye, A. C. (2026a). A conceptual framework review of incentive alignment mechanisms between payers and providers in value-based care contracting and their effects on cost and quality outcomes. Journal of Public Administration and Social Welfare Research, 11(1), 111-133. https://doi.org/10.56201/jpaswr.v11.no1.2026.pg111.133
106) Ilodigwe, L., & Adesemoye, A. C. (2026b). Reimagining population health: An integrated conceptual model combining value-based care, digital health innovation, and health equity for sustainable system transformation. International Journal of Health and Pharmaceutical Research, 11(5), 157-176. https://doi.org/10.56201/ijhpr.vol.11.no5.2026.pg157.176
107) Improvado. (2026). Pharma ad compliance 2026: FDA fair balance and ISI rules. https://improvado.io/blog/pharma-ad-compliance-fda-ftc-fair-balance-and-isi-requirements
108) Influence of EU pharmaceutical legislation on access to medicines in low- and middle-income countries. (2025). PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC12049977
109) ISPOR. (2026). International reference pricing comes to America: The MFN policies explained. Value and Outcomes Spotlight.
https://www.ispor.org/publications/journals/value-outcomes-spotlight
110) Journal of Medical Internet Research. (2026). Affordable GLP-1? When digital platforms meet policy reform. JMIR, 2026(1), e102069.
https://www.jmir.org/2026/1/e102069
111) King, A. (2025, February 7). Ahead of big sports weekend, King introduces legislation to prohibit direct-to-consumer pharmaceutical drug advertising [Press release]. United States Senate. https://www.king.senate.gov/newsroom/press-releases/
112) Kumuyi, O., Akeju, B., Uzoka, E., & Ozowara, D. E. (2023). Framework for blockchain-based cross-border data exchange and regulatory transparency. International Journal of Multidisciplinary Futuristic Development, 4(1), 99-113.
113) Kumuyi, O., Uzoka, E., Akeju, B., & Ozowara, D. E. (2024a). Architecture for machine learning-enabled predictive energy management using IoT sensor networks. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 3138-3149.
https://doi.org/10.62225/2583049X.2024.4.6.6004
114) Kumuyi, O., Uzoka, E., Akeju, B., & Ozowara, D. E. (2024b). Framework for privacy-focused digital identity verification supporting financial inclusion in Africa. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 3150-3162.
https://doi.org/10.62225/2583049X.2024.4.6.6005
115) Mbonu, I. S., Aliliele, C., Iwuanyanwu, U., & Oluoha, O. M. (2018). A conceptual framework for legal and ethical risk modeling in enterprise data protection governance systems. Iconic Research and Engineering Journals, 2(2), 207-226.
https://doi.org/10.64388/IREV2I2-1714911
116) Mbonu, I. S., Aliliele, C., Iwuanyanwu, U., & Uzoka, E. (2020). A review of identity and access management integration strategies in hybrid and multi cloud environments. International Journal of Multidisciplinary Research and Growth Evaluation, 1(5), 795-810.
https://doi.org/10.54660/.IJMRGE.2020.1.5.795-810
117) Mbonu, I. S., Aliliele, C., Iwuanyanwu, U., & Uzoka, E. (2021a). A conceptual framework for risk based business intelligence architecture in financial technology platforms. International Journal of Multidisciplinary Research and Growth Evaluation, 2(6), 731-746.
https://doi.org/10.54660/.IJMRGE.2021.2.6.731-746
118) Mbonu, I. S., Aliliele, C., Iwuanyanwu, U., & Uzoka, E. (2021b). Advances in artificial intelligence techniques for secure software testing and automated regression control mechanisms. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 7(5), 468-496. https://doi.org/10.32628/CSEIT217565
119) Medscape. (2026, July 30). Manufacturers report $2.6 billion in Open Payments to physicians, but product details remain murky. https://www.medscape.com/viewarticle/manufacturers-report-2-6-billion-open-payments-physicians-2026a1000pxt
120) Mitchell, A. P., Trivedi, N. U., Gennarelli, R. L., Chimonas, S., Tabatabai, S. M., Goldberg, J., Diaz, L. A., & Korenstein, D. (2021). Are financial payments from the pharmaceutical industry associated with physician prescribing? A systematic review. Annals of Internal Medicine, 174(3), 353–361. https://doi.org/10.7326/M20-5665
121) Ogbete, J. C., & Aminu-Ibrahim, A. Y. (2024). Translating healthcare infrastructure investment into measurable population health and diagnostic outcomes. International Journal of Scientific Research in Humanities and Social Sciences, 1(2), 955-985.
https://doi.org/10.32628/IJSRSSH242775
122) Ogbete, J. C., Aminu-Ibrahim, A. Y., & Ambali, K. B. (2018). Optimizing laboratory spatial planning strategies to improve diagnostic accuracy, safety, and clinical throughput. Iconic Research and Engineering Journals, 2(1), 87-113. https://doi.org/10.64388/IREV1I7-1713587
123) Oghenemaiga, E., Basnet, A., & Anene, U. N. (2024). Predictive analytics applications for forecasting traffic patterns across owned and operated media platforms. International Journal of Advanced Multidisciplinary Research and Studies, 4(6).
https://doi.org/10.62225/2583049X.2024.4.6.5668
124) Ogundairo, K. M., & Ayivi-Donkor, S. S. (2023a). Machine learning approaches to customer acquisition and retention: A framework for predictive lifecycle management. IIARD International Journal of Economics and Business Management, 9(10), 210-246.
https://doi.org/10.56201/ijebm.v9.no10.2023.pg210.246
125) Ogundairo, K. M., & Ayivi-Donkor, S. S. (2023b). Telemetry-driven value realization: Infusing economic evaluation algorithms directly into enterprise data pipelines. International Journal of Economics and Financial Management, 8(8), 195-232.
https://doi.org/10.56201/ijefm.v8.no8.2023.pg195.232
126) Ogundairo, K. M., & Ayivi-Donkor, S. S. (2024a). Bridging the "adoption gap": Why supply chain AI fails without product marketing principles. International Journal of Marketing and Communication Studies, 8(5), 169-205.
https://doi.org/10.56201/ijmcs.v8.no5.2024.pg169.205
127) Ogundairo, K. M., & Ayivi-Donkor, S. S. (2024b). The vanishing interface: Why the coming era of autonomous agents demands a paradigm shift in product marketing architecture. IIARD International Journal of Economics and Business Management, 10(11), 350-385. https://doi.org/10.56201/ijebm.v10.no11.2024.pg350.385
128) Ogunwola, T. A., & Alozie, C. (2026). Architecting secure and compliant distributed healthcare networks: Operational approaches to health insurance portability and accountability act and health information trust alliance alignment. International Journal of Computer Applications, 187(111), 1-6.
129) Onche, V. O., Adegbite, M. P., & Ogbonna, C. S. (2026). Human factors in information security: A capability framework for administrative professionals in the digital workplace. World Journal of Innovation and Modern Technology, 10(5), 154-179.
https://doi.org/10.56201/wjimt.v10.no5.2026.pg154.179
130) Onche, V. O., Ogbonna, C. S., & Adegbite, M. P. (2024). Effectiveness of cybersecurity awareness training on insider-threat behavior among university administrators: An integrative academic review. International Journal of Computer Science and Mathematical Theory, 10(2), 117-144. https://doi.org/10.56201/ijcsmt.v10.no2.2024.pg117.144
131) Onwubuya, L. I., Fawehinmi, Y. O., Sunday, D., Igwenagu, M. O., Adeniran, A. O., & Agyapong, E. A. (2026). Adaptive learning systems powered by artificial intelligence for STEM education improvement. Asian Journal of Education and Social Studies, 52(6), 553-566.
https://doi.org/10.9734/ajess/2026/v52i63115
132) Orise, C., & Niniola, S. (2020). Data-informed digital learning platforms: A conceptual framework for evidence-based educational technology in healthcare and STEM environments. International Journal of Multidisciplinary Research and Growth Evaluation, 1(5),
1078-1089. https://doi.org/10.54660/.IJMRGE.2020.1.5.1078-1089
133) Orise, C., & Niniola, S. (2022). Real-time analytics for educational excellence: A conceptual framework for performance dashboards in health professional training. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 8(2), 802-815.
134) Osborne Clarke. (2026, May). EU overhauls pharmaceutical law with sweeping 2026 reform package.
https://www.osborneclarke.com/insights/eu-overhauls-pharmaceutical-law-sweeping-2026-reform-package
135) Ozowara, D. E., Adebayo, A., & Anunagba, C. O. (2022). A systematic review of cybersecurity investments and their impact on healthcare financial performance. Shodhshauryam, International Scientific Refereed Research Journal, 5(1), 404-427.
136) Ozowara, D. E., Adebayo, A., & Anunagba, C. O. (2025a). Advanced conceptual model for strengthening audit quality using data analytics across financial institutions. International Journal of Advanced Multidisciplinary Research and Studies, 5(6), 2246-2268. https://doi.org/10.62225/2583049X.2025.5.6.6050
137) Ozowara, D. E., Anunagba, C. O., & Adepoju, P. A. (2025b). A review of ransomware economics and financial resilience strategies in hospital networks. International Journal of Advanced Multidisciplinary Research and Studies, 5(6), 2284-2298.
https://doi.org/10.62225/2583049X.2025.5.6.6052
138) Pharma Marketing Network. (2025). Pharma marketing in 2026: How AI, policy shifts, and patient-centric strategies will redefine the industry. https://www.pharma-mkting.com/featured/
139) Pharma Marketing Network. (2026, January). FTC pharma promotion rules 2026: What's really "advertising"? https://www.pharma-mkting.com/advertising/ftc-pharma-promotion-rules-2026/
140) Pomeranz, J. L., Hanson, E., & Mozaffarian, D. (2026). Regulating direct-to-consumer prescription drug advertising in the United States. The Milbank Quarterly, 104(1), 0216. https://doi.org/10.1111/1468-0009.70071
141) ProPharma Group. (2026). 2025 FDA promotion enforcement: What pharma must know for 2026.
142) Ropes & Gray LLP. (2026, March). Unpacking the EU pharma package.
https://www.ropesgray.com/en/insights/alerts/2026/03/unpacking-the-eu-pharma-package
143) Sanni, J. O., & Atima, M. E. (2021a). Analytics driven go to market frameworks addressing compliance sustainability complexity. International Journal of Multidisciplinary Research and Growth Evaluation, 2(6), 647-660.
144) Sanni, J. O., & Atima, M. E. (2021b). Business intelligence dashboard frameworks resolving executive visibility gaps in strategic marketing governance. International Journal of Multidisciplinary Research and Growth Evaluation, 2(6), 633-646.
https://doi.org/10.54660/IJMRGE.2021.2.6.633-646
145) Sanni, J. O., & Attah, A. (2023a). A comprehensive framework for digital transformation in capital markets: Solving operational challenges and enhancing stakeholder engagement. Gyanshauryam, International Scientific Refereed Research Journal, 6(6), 275-302.
https://doi.org/10.32628/GISRRJ236640
146) Sanni, J. O., & Attah, A. (2023b). Artificial intelligence assisted content optimization models resolving digital conversion performance bottlenecks issues. Gyanshauryam, International Scientific Refereed Research Journal, 6(6), 303-336.
https://doi.org/10.32628/GISRRJ236641
147) Sanni, J. O., & Attah, A. (2023c). Market research frameworks addressing entry barriers within highly regulated industrial service sectors. International Journal of Scientific Research in Computer Science, Engineering and Information Technology, 10(2), 904-930.
https://doi.org/10.32628/CSEIT2342439
148) Sanni, J. O., & Wedraogo, L. (2024). Data-centric funnel optimization frameworks resolving revenue leakage in high-value services. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 2859-2874.
https://doi.org/10.62225/2583049X.2024.4.6.5641
149) Sanni, J. O. (2026a). Artificial intelligence driven demand forecasting models addressing volatility in complex service organizations. Computer Science & IT Research Journal, 7(1), 1-26. https://doi.org/10.51594/csitrj.v7i1.2170
150) Sanni, J. O. (2026b). Integrated advertising and marketing framework for U.S. retail growth. International Journal of Marketing and Communication Studies, 10(1), 12-36. https://doi.org/10.56201/ijmcs.v10.no1.2026.pg12.36
151) Sanni, J. O. (2026c). Marketing analytics frameworks addressing governance risk compliance decision making gaps for executives. International Journal of Marketing and Communication Studies, 10(1), 37-64. https://doi.org/10.56201/ijmcs.v10.no1.2026.pg37.64
152) Sanni, J. O. (2026d). Predictive marketing frameworks resolving revenue attribution conflicts in regulated professional services environments. World Scientific News, 212, 52-81. https://doi.org/10.65770/QPHC9342
153) Sanni, J. O., Ajiga, D., & Atima, M. E. (2020a). Analytical models addressing measurement challenges of marketing return on investment in regulated services. International Journal of Multidisciplinary Research and Growth Evaluation, 1(5), 636-648.
https://doi.org/10.54660/IJMRGE.2020.1.5.636-648
154) Sanni, J. O., Ajiga, D., & Atima, M. E. (2020b). Data driven brand positioning frameworks resolving differentiation challenges in regulated professional markets. International Journal of Multidisciplinary Research and Growth Evaluation, 1(5), 649-660.
https://doi.org/10.54660/IJMRGE.2020.1.5.649-660
155) Sanni, J. O., Ajiga, D., & Atima, M. E. (2020c). Systematic review of product management strategies in mobile network rollouts across emerging markets. International Journal of Multidisciplinary Research and Growth Evaluation, 1(5), 661-673.
https://doi.org/10.54660/IJMRGE.2020.1.5.661-673
156) Sanni, J. O., Atima, M. E., & Attah, A. (2022a). Systematic review of attribution modeling methods resolving bias in multi-touch journeys. Shodhshauryam, International Scientific Refereed Research Journal, 5(1), 304-334. https://doi.org/10.32628/SHISRRJ247135
157) Sanni, J. O., Iwuanyanwu, U. A., & Essien, M. A. (2025). Problem-oriented process mining for auditable marketing automation lifecycle control. International Journal of Advanced Multidisciplinary Research and Studies, 5(6), 1933-1947.
https://doi.org/10.62225/2583049X.2025.5.6.5650
158) Sanni, J. O., Iwuanyanwu, U. A., & Essien, M. A. (2026). Designing explainable AI based marketing automation architectures for healthcare and financial applications. World Scientific News, 213, 119-148. https://doi.org/10.65770/MJFK8593
159) Sanni, J. O., Iwuanyanwu, U. A., Essien, M. A., & Attah, A. (2023). Lifecycle-aware marketing automation using federated learning for secure cross-organizational data management. Gyanshauryam, International Scientific Refereed Research Journal, 6(6), 337-364. https://doi.org/10.32628/GISRRJ236642
160) Sanni, J. O., Iwuanyanwu, U. A., Essien, M. A., & Wedraogo, L. (2024). Integrating blockchain-enabled smart contracts for transparent and verifiable marketing workflows. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 2891-2906. https://doi.org/10.62225/2583049X.2024.4.6.5646
161) Sanni, J. O., Iwuanyanwu, U. A., Essien, M. A., Atima, M. E., & Attah, A. (2022b). Adaptive control models for AI-driven marketing automation in financial compliance environments. Shodhshauryam, International Scientific Refereed Research Journal, 5(1), 243-270.
https://doi.org/10.32628/SHISRRJ247133
162) Sidley Austin LLP. (2026, April). Most-favored-nation drug pricing policy: Executive actions, manufacturer agreements, and growing congressional scrutiny. https://www.sidley.com/en/insights/newsupdates/2026/04/
163) Spectrum Science. (2026, January). 2026 predictions for healthcare and pharmaceutical marketing.
https://www.spectrumscience.com/perspectives/2026-pharma-marketing-predictions/
164) STAT News. (2026a, March 12). The FDA is targeting telehealth marketing of GLP-1 drugs. Who's prescribing them? https://www.statnews.com/2026/03/12/fda-telehealth-marketing-glp1-prescribers-behind-warning-letters/
165) STAT News. (2026b, July). Secret shopper study reveals questionable telehealth GLP-1 practices.
https://www.statnews.com/2026/07/06/glp-1-telehealth-prescriptions-jama-yale-secret-shopper-study/
166) STAT News. (2026c, May 28). Trump most-favored-nation drug pricing claims clouded by secrecy.
https://www.statnews.com/2026/05/28/trump-most-favored-nation-drug-pricing-secrets-revealed-soon/
167) Tarras, E. S., et al. (2026). Industry payments and prescribing patterns of pulmonary hypertension therapies in the United States. Pulmonary Circulation, 16(1), e70279. https://doi.org/10.1002/pul2.70279
168) Telehealth.org. (2026, August). U.S. News releases first GLP-1 telehealth platform ratings, excludes compounded-only sellers.
169) Venable LLP. (2026, March). FDA's latest GLP-1 crackdown: What compounders and telehealth platforms need to know. https://www.venable.com/insights/publications/2026/03/fdas-latest-glp-1-crackdown-what-compounders
170) Washington Legal Foundation. (2026, March 31). Regulation of consumer drug ads: Legislative dos and don'ts.
https://www.wlf.org/2026/03/31/publishing/regulation-of-consumer-drug-ads-legislative-dos-and-donts/
171) Wedraogo, L., & Sanni, J. O. (2024). Machine learning models addressing uncertainty in cross-channel campaign performance forecasting accuracy. International Journal of Advanced Multidisciplinary Research and Studies, 4(6), 2875-2890.
https://doi.org/10.62225/2583049X.2024.4.6.5648
172) White House. (2026, May). Savings from most-favored-nation drug pricing policy.
https://www.whitehouse.gov/research/2026/05/savings-from-most-favored-nation-drug-pricing-policy/
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Isaac Awulu, Imoiboho Williams (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
